AwardedSpainGoods€14,784,000
Contrato de suministros CONTR 2024 0001031923
- Published
- Published 10 November 2025
Overview
- PNAMSP 133/2024 ACUERDO MARCO CON UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA EL SUMINISTRO DE TRACTO SUCESIVO Y PRECIO UNITARIO DEL MEDICAMENTO EXCLUSIVO IDECABTAGEN VICLEUCEL 400MILL CELULAS/INYECTABLE IV- Forma farmacéutica INYECTABLE IV PARA EL HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO (HUVR), CENTRO ADSCRITO A LA CENTRAL PROVINCIAL DE COMPRAS DE SEVILLA (CPC-SE) MEDIANTE PROCEDIMIENTO NEGOCIADO SIN PUBLICIDAD CON EMPRESA BRISTOL MYERS SQUIBB,S.A.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €14,784,000
- Procedure
- Direct
- Published
- 10 November 2025
Pharmaceutical products
Award outcome
- Awarded value
- €6,349,824
- Award date
- 10 March 2025
- Contract period
- — → 28 February 2027
- Bristol-Myers Squibb, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
10 November 2025
Contracting authority
Servicio Andaluz de Salud. Área Hospitalaria Virgen del Rocío.
Procuring entitySevilla, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.